Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2020

May 5, 2020

284_dirs_2020-05-05_c8e849c6-709c-41a7-9733-0665e05fc3a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-05-01

Reporting Person: Zachary Jennifer (EVP, General Counsel)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-01 Stock Option (Right to Buy) $77.67 A 75514 Acquired 2030-04-30 Common Stock (75514) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3717.498 Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.